Skip to main navigation Skip to search Skip to main content

Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome

  • University Hospitals Limerick
  • Trinity College Dublin, St James's Hospital

Research output: Contribution to journalArticlepeer-review

Abstract

Antiphospholipid syndrome (APS) is an autoimmune multisystem disorder characterised by high incidence of arterial and venous thrombosis. Cardiovascular manifestations also include valvular heart disease, ventricular thrombi and higher risk for coronary artery disease (CAD). In this case report, we describe a 61-year-old woman who had no significant risk factors for CAD, and presented with aggressive disease in native and graft vessels that required multiple coronary interventions. The extent of her aggressive CAD could not be explained by her risk factors profile. Therefore autoantibodies screening was carried out and showed a strongly positive anticardiolipin and β2 glycoprotein-I antibody, and hence a diagnosis of antiphospholipid syndrome was made.

Original languageEnglish
JournalBMJ Case Reports
DOIs
Publication statusPublished - 8 Apr 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome'. Together they form a unique fingerprint.

Cite this